Litcius/Paper detail

Two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for treating locally advanced esophageal cancer: short-term outcomes of a multicenter randomized phase II trial

Osamu Shiraishi, Tomoki Makino, Makoto Yamasaki, Koji Tanaka, Kotaro Yamashita, Tomo Ishida, Keijiro Sugimura, Hiroshi Miyata, Masaaki Motoori, Kazumasa Fujitani, Atsushi Takeno, Motohiro Hirao, Yutaka Kimura, Taroh Satoh, Masahiko Yano, Yuichiro� Doki, Takushi Yasuda

2021Esophagus24 citationsDOI

Topics & Concepts

MedicineDocetaxelEsophageal cancerPerioperativeLeukopeniaRandomized controlled trialInternal medicineFluorouracilAdverse effectChemotherapyCardiothoracic surgeryLung cancerCisplatinAbdominal surgerySurgical oncologySurgeryCancerEsophageal Cancer Research and TreatmentGastric Cancer Management and OutcomesPancreatic and Hepatic Oncology Research
Two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for treating locally advanced esophageal cancer: short-term outcomes of a multicenter randomized phase II trial | Litcius